Eileen Maysek is a research analyst with extensive experience in biotech equity research. Currently serving at Casdin Capital, LLC since 2020, Eileen has advanced from Research Associate to Senior Research Associate. Prior to this role, Eileen held positions at Cantor Fitzgerald and Credit Suisse, focusing on large and small/mid-cap biotech coverage. Eileen began a career in research with internships at Columbia University, specializing in ultrasound elasticity imaging, and also gained experience as a Private Banking Intern at J.P. Morgan. Eileen holds a Bachelor of Science in Biomedical Engineering from Brown University and has further education from Villanova University.
Upgrade to view 0 reports
This person is not in any offices
Casdin Capital
1 followers
Casdin Capital, LLC (āCasdinā) is a New York-based fundamental research investment firm focused on the life sciences and healthcare industry. The firm manages a long short equity fund and makes investments in early stage to late stage private investments. Casdin was launched in 2012 by founder and CIO Eli Casdin and as of October 2020 has approximately $2.2 billion in assets under management. Casdin started from a position of curiosity, honesty, and passion to gain a deep and thoughtful understanding of opportunities in the life science ecosystem. They commit to finding the highest quality management teams doing the work to create high growth companies. They use data to continually advance their knowledge and we are long term investors. They believe in collaboration and transparency and operate at the forefront of innovation.
Ad